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Abstract
Background: The Respiratory Infections in Andean Peruvian Children (RESPIRA-PERU) study enrolled children who
participated in a community-cluster randomized trial of improved stoves, solar water disinfection, and kitchen sinks (IHIP
trial) and children from additional Andean households. We quantified the burden of influenza-associated acute respiratory
illness (ARI) in this household-based cohort.
Methods: From May 2009 to September 2011, we conducted active weekly ARI surveillance in 892 children age,3 years, of
whom 272 (30.5%) had participated in the IHIP trial. We collected nasal swabs during ARI, tested for influenza and other
respiratory viruses by RT-PCR, and determined influenza incidence and risk factors using mixed-effects regression models.
Results: The overall incidence of influenza-associated ARI was 36.6/100 child-years; incidence of influenza A, B, and C was
20.5, 8.7, and 5.2/100 child-years, respectively. Influenza C was associated with fewer days of subjective fever (median 1 vs.
2) and malaise (median 0 vs. 2) compared to influenza A. Non-influenza ARI also resulted in fewer days of fever and malaise,
and fewer healthcare visits than influenza A-associated ARI. Influenza incidence varied by calendar year (80% occurred in the
2010 season) and IHIP trial participation. Among households that participated in the IHIP trial, influenza-associated ARI
incidence was significantly lower in intervention than in control households (RR 0.40, 95% CI: 0.20–0.82).
Conclusions: Influenza burden is high among Andean children. ARI associated with influenza A and B had longer symptom
duration and higher healthcare utilization than influenza C-associated ARI or non-influenza ARI. Environmental community
interventions may reduce influenza morbidity.
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Introduction
Influenza virus is a major cause of childhood morbidity,
generating three to five million severe illnesses and up to
500,000 deaths annually worldwide. [1] Seasonal epidemics are
caused by both influenza A and B, which are the targets of annual
influenza vaccination. Influenza C also causes acute respiratory
illness (ARI), but does not contribute significantly to seasonal
epidemics and is not included in influenza vaccines [2].
Over the past decade, the burden of influenza among children
has been increasingly recognized in both developing [3–5] and
developed nations [6]. The study of Respiratory Infections in
Andean Peruvian Children (RESPIRA-PERU), conducted from
PLOS ONE | www.plosone.org 1 March 2014 | Volume 9 | Issue 3 | e91247
May 2009 to September 2011, documented high rates of acute
respiratory illness (ARI) in Andean Peruvian children [7,8].
Influenza is unique among viral respiratory pathogens in that
illness can be prevented or attenuated by vaccination, and
understanding the burden and temporal circulation of influenza
is important for the implementation of vaccination policy. Using
data from RESPIRA-PERU, we sought to determine the
incidence of laboratory-confirmed influenza in Andean children,
describe the clinical characteristics of these infections, and identify
risk factors for influenza acquisition.
Methods
Ethics statement
The study protocol was approved by the Vanderbilt Institu-
tional Review Board and by the ethics committee of the Instituto
de Investigacio´n Nutricional. Written informed consent was
obtained from a parent or guardian of all children involved in
this study.
RESPIRA-PERU study
RESPIRA-PERU, a prospective household-based study of ARI
conducted in the high-altitude (1500–4000 meters) province of San
Marcos, Cajamarca, Peru has been previously described [7,8].
Families with children ,3 years of age (including newborns) were
enrolled between March, 2009 and August, 2011 and were under
active ARI surveillance from May, 2009 through September,
2011. To capture as many ARI as possible, a highly sensitive ARI
definition (cough or fever) was employed. After obtaining signed
informed consent, field workers obtained baseline demographic
and socioeconomic information and permission to access vacci-
nation and healthcare records for enrolled children. Once
enrolled, children were followed until their 3rd birthday,
withdrawal of consent, loss to follow-up, death, or study end,
whichever came first. Field-workers visited the home of each
enrolled child weekly, interviewed the parent or guardian about
ARI signs/symptoms during the preceding week, and assessed
symptomatic children for World Health Organization-Integrated
Management of Childhood Illness (WHO-IMCI) danger signs
including: tachypnea, wheezing, retractions, grunting, nasal
flaring, stridor, or cyanosis [9]. If the previous weekly visit was
missed, data was collected for the preceding fourteen days, but no
further.
IHIP-Peru community trial
The Integrated Home-based Intervention Package (IHIP) trial
was a community-cluster randomized controlled trial conducted in
San Marcos Province from 2008–2010, that randomized 51 rural
communities to either an intervention (25 communities, 267
households) or control arm (26 communities, 267 households) [10].
At baseline, all homes used open indoor fires for cooking. The
intervention included construction of improved, vented stoves,
kitchen sinks with running water, the promotion of hand washing,
and installation of solar drinking water disinfection units. Control
households received a mother-child psychomotor stimulation
intervention. The IHIP trial enrolled one child (aged 6 to 35
months) per household and children were followed from February
2009 to January 2010. Primary outcomes were the frequency of
diarrhea and acute lower respiratory tract infections (ALRI) in
enrolled children [11,12]. Children who participated in the IHIP
trial were eligible for subsequent enrollment in the RESPIRA-
PERU study if they met enrollment criteria [8].
Nasal swab samples
Workers collected nasal swabs (NS) for each ARI episode at the
first household visit following onset of symptoms as previously
described [6,8,13]. After collection and processing, samples were
shipped on dry ice to Vanderbilt University for detection of the
following respiratory viruses using real-time monoplex RT-PCR as
previously described: [6,14–16] influenza, respiratory syncytial
virus (RSV), human metapneumovirus (MPV), parainfluenza
viruses 1–3 (PIV1–3), human rhinovirus, and adenovirus. For
the purposes of this study only results of testing for influenza
viruses (A, B, and C) will be presented.
Statistical analysis
All statistical analyses were performed using Stata 12.1
(StataCorp, College Station TX).
Incidence calculation
Crude influenza incidence was calculated as the number of
influenza-positive ARI episodes, divided by the cumulative person-
time under observation and at risk. Children were not considered
at risk during an ARI or within 7 days of ARI resolution. Crude
estimates were adjusted to account for recurrence of events within
individuals (some children had more than one confirmed influenza
episode) using zero-inflated negative binomial regression. Poisson
regression was used to calculate incidence for each influenza type.
Comparison of clinical features
The demographic and clinical features of influenza-associated
ARI, other viral ARI, and ARI in which no virus was detected,
were compared using medians and proportions. A mixed-effects
logistic regression model was used to test for significant differences,
accounting for the recurrence of ARI at the level of the individual
child.
Risk factors for influenza infection
Multivariable, mixed-effect Poisson regression modeling, ac-
counting for correlation of influenza infection at the level of the
individual child was used to evaluate potential risk factors for
influenza illness. Only 279 of the 892 children enrolled in
RESPIRA-PERU (31%) had received any influenza vaccination at
any time prior to study end; vaccination status was therefore not
included in the risk factor analysis. Because risk for influenza
infection existed only when influenza was present in the
community, the analysis was limited to months during which
influenza was circulating, defined as any month during which
more than one influenza-positive NS specimen was identified
among study children. To minimize misclassification the analysis
was further restricted to children already under observation at the
start of each influenza season, since children entering observation
during the influenza season may have experienced an influenza
ARI prior to observation onset.
Results
Influenza type, subtype, and incidence
The RESPIRA-PERU study enrolled 892 children from 810
households in 58 communities. These children experienced 4,475
symptomatic ARI episodes over the course of the study and NS
specimens were collected for 3957 (88%) [7]. Influenza was
detected in 258 NS specimens, with the majority of influenza-
positive ARI occurring in 2010, when all three types (A, B, and C)
co-circulated (Figure 1A). Incidence of all influenza episodes was
36.6 per 100 child-years (Table 1); because the study contained
Home Environment Interventions and Influenza Risk
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three influenza seasons but not three complete calendar years, this
may overestimate the true annual risk. Monthly influenza
incidence ranged from 0 to 112 influenza-positive ARI per 100
child years and was highest in October – December (Figure 1,
Table S1). Subtype A(H1N1)pdm09 was the predominant isolate
in 2009 and 2011, while seasonal H3N2 virus was predominant in
2010 (Figure 1B). Among the 155 influenza A infections, 72 (46%)
were A(H1N1)pdm09, 81 (52%) were H3N2, and 3 (2%) were
indeterminate. There were 35 children with two influenza-positive
ARI during the study period, and one child who had three. All of
the children with two or more influenza-positive ARI experienced
their second (or third) infection in 2010; the vast majority also had
their first infection in 2010 (Table 2). Reinfection with the same
type was rare. Five children experienced multiple influenza A
episodes; three contracted both A(H1N1)pdm09 and H3N2
infections in the 2010 influenza season, the other two had
A(H1N1)pdm09-associated ARI in 2009 and H3N2-associated
ARI in 2010. Two children had recurrent influenza B-associated
ARI; each had their first influenza-positive ARI in September,
2010 and a second influenza B-associated ARI in October, 2010,
potentially indicating prolonged shedding rather than new
infection. Co-detection of non-influenza study viruses occurred
in 71 (28%) of the 258 influenza-associated episodes; among these
were 54 (76%) human rhinovirus, 22 (31%) adenovirus, and 15
(21%) PIV1-3 coinfections, and one (1%) RSV co-infection.
Characteristics of influenza-associated ARI
The characteristics of influenza ARI, non-influenza viral ARI,
and ARI in which no study virus was identified are compared in
Tables 3 and 4. Influenza illness was more common in 2010. A
higher proportion of influenza ARI occurred in the 2nd altitude
quartile, and fewer in the 4th, compared to other ARI (Table 3).
There were no significant differences in symptom duration,
presence of WHO-IMCI danger signs, or hospitalization rates
between influenza types A and B, but influenza type C-associated
ARI had significantly fewer days of fever and malaise (Table 4).
ARI positive for non-influenza viruses also had fewer days fever
and malaise, as well as proportionally fewer healthcare visits,
compared to influenza A. Influenza A or B-associated ARI had
more days of symptoms and were more likely to prompt a
healthcare visit than other ARI (Table 4).
Risk factors for influenza illness
Aside from calendar year, the only factor significantly associated
with reduced influenza incidence in multivariable modeling was
household participation in the IHIP community trial (Table 5).
Compared to children from households not using improved stoves
and not in the IHIP trial, children in IHIP intervention households
had a relative risk (RR) for influenza-associated illness of 0.35
Figure 1. Seasonality of influenza-associated ARI.
doi:10.1371/journal.pone.0091247.g001
Table 1. Influenza incidence per 100 child-years.
Influenza type and subtype Cases Incidence (95% CI)
Influenza A (all subtypes) 155* 20.5 (17.5–24.0)
A(H1N1)pdm09 72 9.5 (7.6–12.0)
H3N2 81 10.7 (8.6–13.3)
Influenza B 66 8.7 (6.9–11.1)
Influenza C 39 5.2 (3.8–7.1)
Total 258{ 36.6 (31.0–43.3)
*One sample tested positive for both pandemic H1N1 and H3N2 and 3 were
untypable.
{Total does not equal sum of A+B+C because 2 samples contained more than
one influenza strain.
doi:10.1371/journal.pone.0091247.t001
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(95% CI 0.19–0.62), while children living in IHIP control
households had a RR of 0.61 (95% CI 0.37–0.98).
Subgroup analysis of IHIP trial households
A separate subgroup analysis including only children who had
been in the IHIP trial (N= 105 from intervention households and
112 from control households) showed 11 influenza ARI over 32.5
child-years among children from intervention households and 26
influenza ARI over 34.3 child-years among children from control
households. In multivariable analysis including calendar year, age,
and gender, children in IHIP intervention households had a RR
for influenza illness of 0.40 (95% CI 0.20–0.82), compared to
children from control households.
Discussion
Influenza is increasingly recognized as an important cause of
severe respiratory infection in children worldwide [3–6,17,18].
The incidence of influenza illness among RESPIRA-PERU cohort
children was high, with rates of 20.5, 8.7 and 5.2/100 child-years
for influenza A, B and C, respectively. ARI positive for influenza A
or B lasted longer, had more days of fever and malaise, and
resulted in more healthcare encounters than non-influenza ARI.
The incidence of influenza ARI observed in RESPIRA-PERU
(36.6/100 child-years) is higher than seen in recent household-
based studies in other developing nations. A study in Dhaka,
Bangladesh from 2004 to 2007 estimated an annual influenza risk
of 10% among children ,5 years of age, using viral culture to
document influenza infection among children with fever or
respiratory symptoms [4]. The use of RT-PCR rather than
culture in our cohort, and seasonal variation in influenza
circulation are factors that may contribute to the higher rates
observed in our study. Like our study, the Dhaka study found
more fever and malaise among influenza than non-influenza ARI.
A study in Vietnam from 2007–2010 reported a seasonal risk of
influenza infection of 41.8% among children aged 5–9 years (no
similar data for younger children were reported), using a
combination of serology and RT-PCR of NS samples [19].
Despite active weekly surveillance, the Vietnam study found that
only 11–16% of laboratory-confirmed influenza infections corre-
lated with an episode of influenza-like-illnesses (ILI, defined as
fever plus either cough or sore throat), suggesting that many
influenza infections did not result in typical ILI symptoms.
Because our study did not employ serologic testing it is unclear
how many influenza infections escaped detection by symptomatic
surveillance; however, the proportion of undetected infections is
likely to be lower for several reasons. First, a more sensitive ARI
definition (fever or cough) was used. Of the 258 influenza ARI in
our study, 70 (28%) had either fever or cough, but not both, and
thus may not have met the Vietnam study definition for ILI (our
study did not collect data on sore throat). Second, a higher
proportion of influenza episodes in our study were due to
pandemic A(H1N1)pdm09, which was more likely to cause
symptoms among young children [18]. Finally, both studies relied
on parental report of fever and the Vietnam study authors
speculate there may have been under-reporting of fever by parents
in their study [19].
Some important aspects of our study should be noted when
comparing the results to other studies. RESPIRA-PERU was
designed to capture all ARI episodes among cohort children and
NS samples were collected only once per episode. Recurrence of
fever or cough within 7 days of an antecedent ARI episode was
considered an extension of the prior ARI, and not counted as a
new episode. Thus, children were not considered at-risk for a new
ARI during a symptomatic episode and for seven days thereafter,
and this time not-at-risk was excluded from the person-time
denominator. On average, children in RESPIRA-PERU experi-
enced 6 ARI/year, lasting approximately five days each [7].
Therefore, our exclusion of person-time not at-risk yielded an
influenza incidence estimate approximately 26% higher than if
time not at-risk had been included. In addition, our surveillance
period included three influenza seasons (2009–2011), but only 29
total months, potentially enriching our observation period with
time when influenza was circulating. Thus, our influenza ARI
incidence estimates, while accurate for the months observed, may
overestimate the true annual risk.
Multiple aspects of the physical environment in which children
in the RESPIRA-PERU cohort live may affect their susceptibility
to respiratory infection. While living in a remote location might
insulate households from circulating infections [20], harsh winters
may cause indoor crowding and increased exposure to household
air pollution. A potential protective effect of remote location
during the 1918 influenza epidemic has been suggested [21], yet
even the most remote locations are unlikely to be insulated from
Table 2. Number of Children Experiencing Multiple Influenza Episodes.
Second influenza virus detected (calendar year 2010)*
First Influenza Virus A(H1N1)pdm09 H3N2 Influenza B Influenza C Total
Calendar Year 2009
Influenza A(H1N1)pdm09 0 2 1 2 5
Influenza A H3N2 0 0 0 0 0
Influenza B 0 0 0 0 0
Influenza C 0 1 0 0 1
Calendar Year 2010
Influenza A(H1N1)pdm09 0 3 0 2 5
Influenza A H3N2 0 0 0 5 5
Influenza B 2{ 13 2{ 0 17
Influenza C 0 1 3 0 4
*All second infections occurred in calendar year 2010.
{Two children had influenza B detected twice during 2010; one of these children also subsequently had influenza A(H1N1)pdma09 detected the same season.
doi:10.1371/journal.pone.0091247.t002
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influenza transmission in the modern era of global mobility.
Indeed, influenza caused substantial morbidity in the communities
in the RESPIRA-PERU study despite their remote location.
Although we did not assess the social interactions or contact
patterns during influenza epidemics, additional information on
this subject would be useful. Study communities had low
population density (about 40 persons per km2), yet the high
incidence of influenza in our study compared to that observed in
highly crowded Bangladesh [3,5] does not suggest any protective
effect of low population density.
Previous studies have shown that Andean Peruvian children are
at higher risk for hypoxia with ARI [22], and have higher ARI-
related mortality than children in lower-altitude provinces [23].
We observed no association between altitude quartile and risk of
influenza-associated ARI in RESPIRA-PERU. Interestingly, the
odds of both hospitalization and death among patients with
laboratory confirmed influenza A(H1N1)pdm09 in Mexico
increased with increasing altitude quintile up to 1765 meters,
but did not increase between the fourth (1765–2229 meters) and
fifth (2230–2850 meters) quintiles, suggesting the effect of altitude
may plateau at very high elevations [24]. Perhaps we observed no
effect of altitude in the current study because all communities in
San Marcos are located above 1900 meters.
Only 4% of influenza-associated ARI in the RESPIRA-PERU
study met WHO-IMCI criteria for severity, a proportion lower
than for RSV, MPV, PIV 1–3, and even adenovirus [7]. This may
be because fever and malaise, rather than respiratory distress or
wheezing, were the distinguishing features for influenza-associated
illness in our study. The proportion of influenza episodes
prompting healthcare visits, a surrogate for the perceived severity
of infection, was 37% and 47% for influenza A and B, respectively,
percentages equaled only by RSV among viral causes of ARI [7].
ARI associated with influenza A or B detection were also longer
and had more days fever and malaise than ARI associated with
Table 3. Child characteristics associated with each symptomatic ARI episode that was tested for the presence of respiratory
viruses.
Characteristic Influenza ARI (N=258)
Non-influenza viral
ARI (N=2390) Other ARI (N=1309)
Male 49.2 (43.1–55.3) 52.0 (50.0–54.0) 52.7 (50.0–55.4)
Age in months, mean (95% CI) 16.3 (15.1–17.5) 15.8 (15.4–16.2) 14.1 (13.6–14.7)*
Calendar year
2009 15.5 (11.1–19.9) 18.7 (17.2–20.4) 26.4 (24.0–28.8)*
2010 80.6 (75.8–85.4) 44.4 (42.4–46.4)* 48.4 (45.7–51.1)*
2011 3.9 (1.5–6.2) 3.67 (3.59–3.87)* 2.51 (2.27–2.75)*
Observation days, mean (95% CI) 425 (406–446) 404 (397–410)* 408 (399–417)
Shares a bed 97.3 (95.3–99.2) 97.2 (96.6–97.9) 96.1 (95.1–97.1)
Attends daycare 6.6 (3.6–9.7) 7.4 (6.3–8.4) 6.3 (5.0–7.6)
Household conditions
Persons per household, median (IQR) 4 (5–6) 4 (5–6) 4 (5–6)
Children ,5 years old per household, median (IQR) 1 (1–2) 1 (1–2) 1 (1–2)
Number of rooms in dwelling, median (IQR) 2 (2–3) 2 (2–3) 2 (2–3)
Electricity in home 39.9 (33.9–45.9) 41.1 (39.2–43.1) 43.1 (40.5–45.8)
Water from pipeline or well 84.1 (79.6–88.6) 85.0 (83.6–86.5) 86.5 (84.6–88.3)
Municipal sewer or septic tank 17.8 (13.2–22.4) 20.6 (19.0–22.2) 19.1 (17.0–21.2)
Wood fuel used for cooking 95.3 (92.8–97.9) 95.2 (94.3–96.0) 93.4 (92.0–94.7)
Presence of smoker in home 9.6 (6.0–13.3) 11.1 (9.8–12.4) 10.3 (8.6–11.9)
Father a laborer 80.6 (75.8–85.4) 82.0 (80.4–83.5) 80.7 (78.6–82.9)
Mother did not complete secondary education 89.8 (86.1–93.5) 88.5 (87.2–89.8) 87.1 (85.3–89.0)
% Distribution in each altitude quartile
Q1) 1976–2321 meters (N = 195 children) 23.6 (18.4–28.8) 27.2 (25.5–29.1) 28.0 (25.5–30.4)
Q2) 2322–2641 meters (N = 189 children) 31.4 (25.7–37.1) 23.2 (21.5–24.9)* 24.4 (22.0–26.7)*
Q3) 2643–2869 meters (N = 199 children) 26.7 (21.3–32.2) 24.4 (22.7–26.1) 26.2 (23.8–28.6)
Q4) 2870–3803 meters (N = 189 children) 18.2 (13.5–22.9) 25.1 (23.3–26.8)* 21.5 (19.2–23.7)
Household in IHIP trial{
No, open stove (N = 376 children) 60.8 (54.9–66.8) 58.0 (55.0–59.2) 57.1 (54.5–59.8)
No, improved stove (N = 133 children) 14.7 (10.4–19.1) 16.3 (14.8–17.8) 17.6 (15.6–19.7)
Yes, control arm (N= 136 children) 15.9 (11.4–20.4) 14.6 (13.2–16.1) 13.1 (11.3–15.0)
Yes, intervention arm (N= 127 children) 8.5 (5.1–11.9) 11.8 (10.5–13.1) 12.1 (10.3 –13.8)
Data represent percentages (95% CI) unless otherwise indicated.
*P,0.05 for strength of association in logistic regression model, adjusting for correlation at the level of the individual child.
{In total, 772 (86.5%) of the 892 children enrolled in the study had at least one ARI for which a NS sample was tested.
doi:10.1371/journal.pone.0091247.t003
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Table 4. Clinical attributes of influenza-associated acute respiratory illnesses (ARI) episodes vs. non-influenza episodes among ARI
episodes for which nasal swab samples were collected.
Attribute
Influenza A
(N=153)
Influenza B
(N=64)
Influenza C
(N=39)
All Influenza
{(N=258)
Non-influenza
viral ARI
(N=2,390)
Other ARI
(N=1,390)
Age in months, mean (95% CI) 15.9 (14.3–17.4) 17.6 (14.9–20.4) 16.5 (13.1–19.9) 16.3 (15.1–17.5) 15.8 (15.4–16.2) 14.1 (13.6–14.7)*
Male (%) 49.7 (41.8–57.6) 39.1 (27.1–51.0) 64.1 (49.0–79.2) 49.2 (43.1–55.3) 52.0 (50.0–54.0) 52.7 (50.0–55.4)
Days with symptoms, median (IQR) 6 (4–9) 7 (4.5–9.5) 6 (4–10) 6.5 (4–9) 5 (3–9) 4 (2–8)*
Fever 2 (1–4) 2 (1–4) 1 (0–2)* 2 (1–3) 1 (0–2)* 2 (1–3)*
Cough 5 (3–8) 6 (3–8.5) 5 (3–10) 5 (3–9) 5 (2–8) 3 (0–6)*
Malaise 2 (0–4) 2.5 (0–5) 0 (0–2)* 2 (0–4) 0 (0–2)* 0 (0–2)*
Rhinorrhea 5 (3–8) 6 (3–9) 5 (3–9) 5 (3–8) 4 (2–7) 2 (0–5)*
Exam for severity performed (%) 67.3 (59.9–74.8) 64.1 (52.3–75.8) 74.4 (60.7–88.1) 67.1 (61.3–72.8) 65.6 (63.7–67.5) 44.2 (41.5–46.9)*
WHO-IMCI danger signs present (%) 6.8 (1.9–11.7) 7.3 (0.0–15.3) 6.9 (0.0–16.1) 6.9 (3.2–10.7) 8.0 (6.7–9.4) 6.2 (4.3–8.2)
Healthcare visit (%) 36.6 (29.0–44.2) 46.9 (34.6–59.1) 25.6 (11.9–39.3) 37.6 (31.7–43.5) 23.3 (21.7–25.0)* 24.1 (21.8–26.5)*
Hospitalization (%) 0.7 (0.0–1.9) 3.1 (0.0–7.4) 0 1.2 (20.1–2.3) 1.0 (0.6–1.5) 0.6 (0.2–1.0)
*P value vs. Influenza A,0.05 using mixed effect logistic regression to account for .1 ARI episode per child.
{Total does not equal sum of A+B+C because 2 samples contained more than one influenza strain.
doi:10.1371/journal.pone.0091247.t004
Table 5. Risk factors for influenza incidence among children under observation during months of influenza circulation.
Univariate analysis Multivariate analysis
Relative risk (95% CI) P value Relative risk (95% CI) P value
Age 1.00 (0.98–1.01) 0.655 1.01 (1.00–1.03) 0.158
Male gender 0.96 (0.73–1.26) 0.759 0.95 (0.72–1.26) 0.732
Calendar year
2009 reference reference
2010 2.46 (1.55–3.91) ,0.001 1.80 (1.07–3.01) 0.025
2011 0.28 (0.12–0.67) 0.004 0.16 (0.06–0.41) ,0.001
Crowding
Persons per room 0.95 (0.87–1.05) 0.342 0.99 (0.89–1.09) 0.815
Child shares a bed 1.20 (0.49–2.91) 0.688 1.17 (0.47–2.88) 0.736
Attends day-care 1.12 (0.67–1.86) 0.671 1.07 (0.63–1.81) 0.800
Physical environment
Water from well or pipeline 0.90 (0.62–1.30) 0.581 0.93 (0.63–1.36) 0.690
Municipal sewer or septic tank 0.79 (0.55–1.14) 0.215 0.88 (0.60–1.29) 0.513
Electricity 1.01 (0.76–1.33) 0.967 0.96 (0.68–1.34) 0.793
Wood primary cook fuel 1.44 (0.74–2.82) 0.281 1.11 (0.52–2.34) 0.79
Altitude quartile
1) 1976–2321 meters reference reference
2) 2322–2641 meters 1.34 (0.92–1.97) 0.132 1.29 (0.86–1.94) 0.212
3) 2643–2869 meters 1.13 (0.77–1.66) 0.539 1.23 (0.81–1.87) 0.337
4) 2870–3803 meters 0.83 (0.55–1.26) 0.385 0.88 (0.55–1.42) 0.605
Household participation in IHIP trial
Non-participant, open stove reference reference
Non-participant, improved stove 0.70 (0.47–1.06) 0.09 0.73 (.047–1.14) 0.169
Participant, control arm 0.72 (0.49–1.07) 0.107 0.61 (0.37–0.98) 0.042
Participant, intervention arm 0.43 (0.26–0.71) 0.001 0.35 (0.19–0.62) ,0.001
doi:10.1371/journal.pone.0091247.t005
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other viruses and those from which no viruses were detected.
Therefore, the low percentage of influenza-ARI classified as severe
in this study should not be misinterpreted as suggesting low
morbidity.
The association between enrollment in the IHIP trial [10] and
decreased risk for influenza is intriguing, but difficulty to interpret.
No significant difference in overall ALRI between communities
randomized to intervention or control households was observed in
the IHIP trial (Hartinger et al., unpublished data), yet the IHIP
trial did not ascertain ARI etiology. Our observation that children
in both arms of the IHIP trial had a lower risk of influenza-ARI
than children from households not participating in the trial
suggests that some factor common to both groups (perhaps
enhanced general hygiene awareness secondary to IHIP trial
participation) contributed to this finding. Although age and
calendar year were obvious potential confounders, the association
remained significant after adjustment for these variables. Impor-
tantly, when our analyses were restricted to the subset of children
that participated in the IHIP trial, those in the intervention arm
had significantly lower influenza rates than those in the control
arm. Whether this is due to a specific component of the
intervention, the combined effect of multiple components or to
other factors is unknown. Hand washing, one component of the
IHIP intervention, has previously been shown to reduce ARI and
pneumonia incidence in low-resource settings [25].
Our study has some important limitations. First, we did not
employ serologic testing and NS samples were taken only during
symptomatic ARI episodes. As discussed above, several serologic
studies suggest that not all influenza infections are symptomatic
enough to be detected by active ARI surveillance [19,26–28]. This
may have led to misclassification of some children in our risk factor
analysis. However, there is no reason to suspect differential
misclassification according to household participation in the IHIP
trial. To reduce the potential for misclassification we limited our
risk factor analyses to months during which influenza was
circulating and to children under observation at the onset of each
influenza season. Of note, removing these restrictions (i.e.
examining influenza cases detected at any time and in all enrolled
children) yielded equivalent results (relative risk of influenza 0.26
[95% CI 0.16–0.44] among IHIP intervention households and
0.49 [95% CI 0.32–0.75] among IHIP trial control households).
Second, the inherent seasonal variation in influenza limits our
ability to draw general conclusions about influenza burden in
Andean children, particularly since a large proportion of cases
were influenza A(H1N1)pdm09, which disproportionately affected
young children [18]. However, comparison to studies in other
locations suggests that influenza burden among Andean children is
among the highest reported for concurrent influenza seasons
[3,5,19]. Third, as discussed above, the low percentage of
influenza-associated ARI categorized as severe in our study likely
underrepresents the perceived morbidity caused by influenza.
Finally, we were unable to conduct any analysis of influenza
vaccine effectiveness in this population, as less than a third of study
children received an influenza vaccine at any time, and much of
that use was seasonal vaccine rather than pandemic influenza
vaccine.
In conclusion, the incidence of influenza-associated illness
among Peruvian Andean children during the 2009–2011 influenza
seasons was high. Influenza type A and B infections resulted in
more days with fever and malaise and a higher rate of care-seeking
than ARI from which other viruses or no virus was detected.
Given the low vaccination coverage among cohort children, a
substantial amount of respiratory morbidity in Andean children
might be averted by universal influenza vaccination. In addition,
we found that a home-based intervention targeting home hygiene
and indoor air pollution was associated with a substantial
reduction in influenza ARI risk among children who participated
in the IHIP trial. This suggests an additional role for environ-
mental modifications in prevention of influenza morbidity in this
setting.
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